Abstract

ASCL1 is a pioneer factor that can reprogram somatic cells to produce neurons. Preventing ASCL1 from being phosphorylated appears to enhance its reprogramming abilities, but the reason for this is unclear. A new paper in Development explores how ASCL1 activity is affected by different cellular contexts and reveals that the basis of the reprogramming efficiency of ASCL1 is more complicated than it first appears. To learn more about the story behind the paper, we caught up with first author Roberta Azzarelli, who is now a Lecturer in Pharmacology at University College London, UK, and corresponding author Anna Philpott, Professor of Cancer and Developmental Biology at the University of Cambridge, UK.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.